31.9 %In COVID-19 patients (n = 266), 31.9% responded to the RBM antigen.
MaliCOVID-19HAL · Unilimdocument of 67 observations
Explore evidence
Gold tier: mechanically validated evidence, with its primary source.
137 evidence items · page 4 / 6
1.32 AORWomen had an adjusted odds ratio of 1.32 for SARS-CoV-2 seropositivity.
MaliCOVID-19HAL · Unilimdocument of 88 observations
9 deathsIn Tombouctou health district, there were 9 deaths due to COVID-19.
MaliCOVID-19HAL · Unilimdocument of 88 observations
0.003 R_valueThere was no significant correlation between antibody responses against S and RBM (R = 0.003, p = 0.9).
MaliCOVID-19HAL · Unilimdocument of 67 observations
743 deathsIn November 2023, Mali officially recorded 743 COVID-19-related deaths.
MaliCOVID-19observed November 2023published 2025PLOS global public healtheurope_pmcdocument of 3 observations
20 %Seroprevalence in the neighborhoods ranged from 20% to 47%.
MaliCOVID-19HAL · Unilimdocument of 88 observations
0.371 ODIn the COVID-19 patient group, the median optical density (OD) for anti-RBD antibody was 0.371 (Q1; Q3: 0.229; 0.873) in males and 0.390 (Q1; Q3: 0.213; 0.887) in females.
MaliCOVID-19HAL · Unilimdocument of 67 observations
598 casesThe reported number of COVID-19 cases in the Tombouctou population was 598.
MaliCOVID-19HAL · Unilimdocument of 88 observations
5.47 IRRParticipants living in households with more than one positive case had an incidence rate ratio of 5.47 for SARS-CoV-2 seropositivity.
MaliCOVID-19HAL · Unilimdocument of 88 observations
43.1 USDLe coût moyen par test antigénique rapide pour la COVID-19 était de 43,1 USD dans le bras intervention et de 1 449,2 USD dans le bras SOC.
MaliCOVID-19HAL · Unilimdocument of 36 observations
36,046 casAu 31 janvier 2022, 36 046 cas de COVID-19 avaient été signalés au Mali.
MaliCOVID-19observed 31 janvier 2022HAL · Unilimdocument of 36 observations
156 deathsThe estimated number of COVID-19 deaths in the Tombouctou population was 156.
MaliCOVID-19HAL · Unilimdocument of 88 observations
33,160 casesFrom January 3, 2020, to November 22, 2023, 33,160 confirmed cases of COVID-19 have been reported in Mali.
MaliCOVID-19observed January 3, 2020 to November 22, 2023HAL · Unilimdocument of 88 observations
200,000,000 casesMore than 200 million cases and over 4 million deaths have been reported worldwide for COVID-19.
MaliCOVID-19HAL · Unilimdocument of 67 observations
22,295 casesThe expected total number of SARS-CoV-2 infections in the population of Tombouctou (70,000 inhabitants) from the start of the epidemic until January 2021 was 22,295 cases.
MaliCOVID-19observed January 2021HAL · Unilimdocument of 88 observations
99.5 %Parmi les 386 tests antigéniques rapides pour la COVID-19 réalisés par les agents de santé communautaires dans le bras intervention, 384 interprétations étaient correctes, soit un taux de bonne interprétation de 99,5 %.
MaliCOVID-19observed 2022HAL · Unilimdocument of 36 observations
532 casesTombouctou health district had over 532 confirmed COVID-19 cases.
MaliCOVID-19HAL · Unilimdocument of 88 observations
2.08 R0The estimated basic reproduction number (R0) for the epidemic in Tombouctou was 2.08.
MaliCOVID-19HAL · Unilimdocument of 88 observations
189 casesThe high-risk cluster of SARS-CoV-2 seropositivity included 189 observed cases against 153 expected cases.
MaliCOVID-19HAL · Unilimdocument of 88 observations
252 per_1000Dans le bras intervention, les agents de santé communautaires ont atteint 1 539 patients et 388 tests antigéniques rapides pour la COVID-19 ont été réalisés, soit 252 tests antigéniques rapides pour 1 000 patients.
MaliCOVID-19HAL · Unilimdocument of 36 observations
21 %A significant proportion of participants believed that COVID-19 was caused by witchcraft (21%).
MaliCOVID-19HAL · Unilimdocument of 88 observations
Higher antibody levels at the time of hospital admission were associated with shorter treatment durations for COVID-19.
MaliCOVID-19HAL · Unilimdocument of 67 observations
2.08 R0The estimated basic reproduction number (R0) of COVID-19 was 2.08.
MaliCOVID-19HAL · Unilimdocument of 88 observations
31.9 %Among 266 COVID-19 samples, 85 (31.9%) recognized the receptor-binding motif (RBM) antigen.
MaliCOVID-19HAL · Unilimdocument of 67 observations
79.5 %In the COVID-19 sample group (N = 266), the prevalence of antibody responders against S was 79.5% among males and 81.7% among females.
MaliCOVID-19 · SARS-CoV-2 S proteinHAL · Unilimdocument of 67 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.